Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy

Published:2019 Issue:4 Volume:22 Page:497
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Li Xinyan¹^ORCID,Wang Mozhi¹^ORCID,Wang Mengshen¹^ORCID,Yu Xueting¹^ORCID,Guo Jingyi¹^ORCID,Sun Tie¹^ORCID,Yao Litong¹^ORCID,Zhang Qiang²^ORCID,Xu Yingying¹^ORCID

Affiliation:

1. Department of Breast Surgery, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.

2. Department of Breast Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, China.

Funder

National Natural Science Foundation of China

Liaoning Science and Technology Project

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://synapse.koreamed.org/pdf/10.4048/jbc.2019.22.e49

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay;Clinical and Translational Oncology;2023-12-09

2. Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment;Medicine;2023-09-29

3. Near-Infrared Spectral Tomography for Predicting Residual Cancer Burden during Early-Stage Neoadjuvant Chemotherapy for Breast Cancer;Clinical Cancer Research;2023-09-21

4. Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial);International Journal of Surgery;2023-06-05

5. Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study;Breast Cancer Research and Treatment;2023-05-23